Red Violet, Inc., an analytics and information solutions company, specializes in proprietary technologies and applying analytical capabilities to deliver identity intelligence in the United States. It offers idiCORE, an investigative solution used to address various organizational challenges, which include due diligence, risk mitigation, identity authentication, fraud detection and prevention, customer acquisition, and regulatory compliance; and FOREWARN, an app-based solution that provides instant knowledge before face-to-face engagement with a consumer, as well as helps professionals to identify and mitigate risk. The company serves financial services, insurance, healthcare, retail, telecommunication companies, law enforcement and government agencies, collections, law, corporate security, and investigative firms. It markets its products and services through value-added distributors, resellers, and strategic partners; and trade shows and seminars, advertising, public relations, distribution of sales literature, and product specifications and ongoing communication with prospective customers, distributors, resellers, strategic partners, and installed base of current customers, as well as through direct sales. Red Violet, Inc. was incorporated in 2017 and is headquartered in Boca Raton, Florida.…
Will Third Quarter Earnings Change Red Violet (RDVT) Narrative
Red Violet (NASDAQ: RDVT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Application industry, part of the Technology sector, and reports about 250 employees.
The shares were at 68.12 USD on 20 November 2026, up 17.0% over 52 weeks. Its 52-week range is 33.40 USD to 83.00 USD: the price is 17.9% below the high and 104.0% above the low.
At a market capitalisation of 1.09B USD, it trades at 57.2 times trailing earnings and 37.2 times forward earnings. The median trailing P/E of its 18 largest Software - Application peers is 33.6, a premium of 70% for RDVT.
Red Violet reports return on equity of 13.0%, an operating margin of 18.7% and revenue up 20.2% year over year.
It holds more cash than debt, a net cash position of 101.78M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 4 analysts cover the stock; their mean price target of 97.00 USD is 42.4% above the current price. The next earnings report is expected on 3 March 2027.